首页> 外文期刊>Clinical nuclear medicine >F-18 FDG PET positive hilar and mediastinal lymphadenopathy mimicking metastatic disease in a melanoma patient treated with interferon-alpha-2b.
【24h】

F-18 FDG PET positive hilar and mediastinal lymphadenopathy mimicking metastatic disease in a melanoma patient treated with interferon-alpha-2b.

机译:F-18 FDG PET阳性肺门和纵隔淋巴结病模拟转移性疾病的黑色素瘤患者接受干扰素-α-2b治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

A 49-year-old man with a history of recurrent melanoma in the parotid was treated with parotidectomy, external beam radiation, and high-dose interferon-alpha-2b. Combined F-18 fluorodeoxyglucose positron emission tomography and computed tomography (FDG PET/CT) performed for restaging demonstrated multiple bilateral hilar and mediastinal hypermetabolic foci corresponding to hilar and mediastinal lymphadenopathy. Cytologic specimens obtained by bronchoscopy were negative for malignancy, revealing reactive lymph nodes. Subsequent FDG PET/CT showed regression of the findings. Awareness of possible interferon-associated reaction in melanoma patients who undergo FDG PET is important to avoid pitfalls in the interpretation.
机译:接受腮腺切除术,外照射和大剂量干扰素-α-2b治疗的49岁男性腮腺有复发性黑色素瘤病史。联合使用F-18氟脱氧葡萄糖正电子发射断层扫描和计算机断层扫描(FDG PET / CT)进行再分期,证实多发性双侧肺门和纵隔高代谢灶与肺门和纵隔淋巴结肿大相对应。支气管镜检查获得的细胞学标本为恶性阴性,显示反应性淋巴结。随后的FDG PET / CT显示结果的回归。对接受FDG PET的黑色素瘤患者可能的干扰素相关反应的认识,对于避免解释中的陷阱很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号